Pilon Fracture Reduction and Functional Outcome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01316289
Recruitment Status : Completed
First Posted : March 16, 2011
Last Update Posted : January 17, 2018
Information provided by (Responsible Party):
AO Clinical Investigation and Documentation

Brief Summary:

This prospective case series will essentially examine the influence of reduction quality on the primary functional outcome (as assessed using the FAAM) of patients with pilon fractures treated with plate fixation.

The plates used in this trial can be chosen according to the preferences of the surgeon.

Condition or disease
Pilon Fracture of Tibia

Detailed Description:
A prospective case series to examine the influence of reduction quality on the primary functional outcome (as assessed using the FAAM) of patients with pilon fractures treated with plate fixation. Radiological parameters including single/combined alignment and various articular measurements will also be validated according to their reliability. The sensitivity of the effects of reduction quality on functional outcome, and an extended evaluation of patient-rated functional and social outcomes as well as their outcome expectations will also be assessed as part of the secondary study aims.

Study Type : Observational
Actual Enrollment : 117 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Quality of Fracture Reduction and Its Influence on Functional Outcome in Patients With Pilon Fractures - a Prospective Multicenter Case Series
Actual Study Start Date : November 2011
Actual Primary Completion Date : January 2017
Actual Study Completion Date : March 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Fractures
U.S. FDA Resources

Primary Outcome Measures :
  1. Examine the influence of reduction quality on the primary functional outcome (as assessed using the Foot and Ankle Ability Measure (FAAM)) of patients with pilon fractures treated with plate fixation. [ Time Frame: 2 years ]
    The most important predictors of functional outcome after pilon fracture will be identified by evaluating the influence of radiologically assessed parameters of reduction quality and other factors (age, high/low energy trauma, AO fracture type, open/closed fracture, delay between trauma and definitive fracture fixation) on the FAAM. In parallel, the radiological parameters will also be validated with respect to their reliability.

Secondary Outcome Measures :
  1. Surgical details [ Time Frame: 1 year ]
    • Length of surgery (skin-to-skin time)
    • Type of implant used
    • Use of bone graft
    • Soft tissue or wound-related procedures (eg, debridement, free flap, local flap, split skin graft)

  2. Pre- and postoperative treatment [ Time Frame: 1 year ]
    Perioperative management data will include documentation of the use of thromboprophylaxis or prophylactic antibiotics, therapeutic antibiotics and pain medication including nonsteroidal antiinflammatory drugs (NSAID).

  3. To assess whether patient and surgeon expectations are met with regard to the trauma outcome [ Time Frame: 1 year ]
    Trauma expectations factor (TEF) to assess the patient and surgeon expectations about the outcome of the treatment

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with pilon fractures that fulfill the following inclusion and exclusion criteria

Inclusion Criteria:

  • Age 18 years and older
  • Patients with a unilateral intraarticular pilon fracture of the distal tibia classified according to AO: AO 43 - B1, B2 and B3 (partial intraarticular) AO 43 - C1, C2 and C3 (total intraarticular)
  • Definitive fracture fixation with a plate within 4 weeks after accident (Temporary fixation with an external fixator, cast or traction is allowed)
  • Signed written informed consent (by the patients) and agreement to attend the planned FU evaluations

Exclusion Criteria:

  • Contralateral fracture of the distal half of the tibia/fibula/talus
  • Pathologic fracture
  • Severe Polytrauma: Injury Severity Score (ISS) > 28
  • Preexisting severe vascular disease (chronic venous insufficiency, chronic arterial occlusive disease)
  • Drug or alcohol abuse
  • American Society of Anesthesiologists (ASA) class V and VI
  • Inability to walk independently prior to injury event
  • Neurological and psychiatric disorders that would preclude reliable assessment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01316289

United States, Indiana
Indiana Orthopaedic Hospital
Indianapolis, Indiana, United States, 46202
United States, Minnesota
University of Minnesota
Saint Paul, Minnesota, United States, 55101
United States, Mississippi
University of Mississippi Medical Center
Jackson, Mississippi, United States, 39216
United States, Washington
Harborview Medical Center
Seattle, Washington, United States, 98104
Medical University Innsbruck
Innsbruck, Austria, 6020
Universidade de São Paulo - Faculdade de Medicina
São Paulo, CEP, Brazil, 05403-010
Cantonal Hospital Graubuenden
Chur, Switzerland, 7000
Cantonal Hospital Luzern
Luzern, Switzerland, 6000
Cantonal Hospital Winterthur
Winterthur, Switzerland, 8401
Sponsors and Collaborators
AO Clinical Investigation and Documentation
Principal Investigator: Christoph Sommer, MD Cantonal Hospital Graubuenden
Study Director: Martin Schuler, PhD AO Clinical Investigation and Documentation, Davos, Switzerland

Additional Information:
Responsible Party: AO Clinical Investigation and Documentation Identifier: NCT01316289     History of Changes
Other Study ID Numbers: Pilon
First Posted: March 16, 2011    Key Record Dates
Last Update Posted: January 17, 2018
Last Verified: January 2018

Keywords provided by AO Clinical Investigation and Documentation:
tibial fractures
pilon fractures
tibial plafond
reduction quality
anatomical reduction
functional outcome
ankle joint

Additional relevant MeSH terms:
Fractures, Bone
Tibial Fractures
Wounds and Injuries
Leg Injuries